2-11155672-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_152391.5(SLC66A3):āc.126A>Cā(p.Leu42Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000406 in 1,454,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152391.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 151974Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000951 AC: 1AN: 105188Hom.: 0 AF XY: 0.0000163 AC XY: 1AN XY: 61192
GnomAD4 exome AF: 0.00000921 AC: 12AN: 1302230Hom.: 0 Cov.: 31 AF XY: 0.00000937 AC XY: 6AN XY: 640408
GnomAD4 genome AF: 0.000309 AC: 47AN: 151974Hom.: 0 Cov.: 32 AF XY: 0.000391 AC XY: 29AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.126A>C (p.L42F) alteration is located in exon 1 (coding exon 1) of the PQLC3 gene. This alteration results from a A to C substitution at nucleotide position 126, causing the leucine (L) at amino acid position 42 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at